Hui Du

565 total citations
20 papers, 406 citations indexed

About

Hui Du is a scholar working on Molecular Biology, Obstetrics and Gynecology and Cancer Research. According to data from OpenAlex, Hui Du has authored 20 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Obstetrics and Gynecology and 5 papers in Cancer Research. Recurrent topics in Hui Du's work include Endometrial and Cervical Cancer Treatments (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Maternal and Perinatal Health Interventions (2 papers). Hui Du is often cited by papers focused on Endometrial and Cervical Cancer Treatments (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Maternal and Perinatal Health Interventions (2 papers). Hui Du collaborates with scholars based in China, United States and Spain. Hui Du's co-authors include Qi Qian, Patrick G. Dean, Vicente E. Torres, Bernard F. King, Fernando G. Cosio, Ying Chen, Chunde Bao, Shun‐le Chen, Kusuki Nishioka and Jie Chen and has published in prestigious journals such as Journal of the American Society of Nephrology, Biochemical Pharmacology and International Journal of Biological Macromolecules.

In The Last Decade

Hui Du

16 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui Du China 11 182 143 81 61 44 20 406
Fubin Liu China 13 201 1.1× 28 0.2× 59 0.7× 52 0.9× 117 2.7× 40 467
Yoo Jin Shin South Korea 12 225 1.2× 43 0.3× 48 0.6× 25 0.4× 21 0.5× 29 446
Xinyi Tang China 12 127 0.7× 42 0.3× 75 0.9× 11 0.2× 59 1.3× 39 399
Suzan Çınar Türkiye 14 104 0.6× 38 0.3× 29 0.4× 28 0.5× 44 1.0× 53 414
Xinglong Zhong China 7 202 1.1× 26 0.2× 68 0.8× 20 0.3× 41 0.9× 11 434
Kainat Khan India 13 255 1.4× 42 0.3× 21 0.3× 20 0.3× 39 0.9× 24 440
Yuka Ueda Japan 15 155 0.9× 33 0.2× 52 0.6× 29 0.5× 16 0.4× 48 482
Vidya S. Farook United States 13 198 1.1× 122 0.9× 144 1.8× 14 0.2× 23 0.5× 29 515
Agnieszka Korobowicz Poland 10 85 0.5× 50 0.3× 43 0.5× 53 0.9× 14 0.3× 19 312
Jae Sik Kim South Korea 11 102 0.6× 45 0.3× 77 1.0× 25 0.4× 28 0.6× 36 520

Countries citing papers authored by Hui Du

Since Specialization
Citations

This map shows the geographic impact of Hui Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Du more than expected).

Fields of papers citing papers by Hui Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Du. The network helps show where Hui Du may publish in the future.

Co-authorship network of co-authors of Hui Du

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Du. A scholar is included among the top collaborators of Hui Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Du. Hui Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Zhi, Jing Zuo, Ruiyu Zhang, et al.. (2025). Activated Notch1 promotes macrophage polarization and exacerbates sepsis-induced acute lung injury via β-catenin/NF-κB signaling. Biochemical Pharmacology. 236. 116892–116892. 1 indexed citations
2.
Du, Hui, et al.. (2025). Therapeutic effect of cardiac rehabilitation on patients with long COVID combined with coronary heart disease: a retrospective study. Frontiers in Cardiovascular Medicine. 12. 1560243–1560243.
3.
Du, Hui, Jihan Huang, Chunyan Wang, et al.. (2025). Analyzing MASLD interventional clinical trial registration based on the ClinicalTrials.gov database. BMC Gastroenterology. 25(1). 148–148. 3 indexed citations
4.
Du, Hui, et al.. (2025). Gentle fundal pressure to facilitate vaginal delivery: A randomized clinical trial. Acta Obstetricia Et Gynecologica Scandinavica. 104(7). 1357–1365.
6.
Du, Hui, et al.. (2024). Segetalin B promotes bone formation in ovariectomized mice by activating PLD1/SIRT1 signaling to inhibit γ-secretase-mediated Notch1 overactivation. The Journal of Steroid Biochemistry and Molecular Biology. 247. 106669–106669.
8.
Chen, Xu, Hao Wu, Ozioma Udochukwu Akakuru, et al.. (2022). Ultrasound-visualized nanocarriers with siRNA for targeted inhibition of M2-like TAM polarization to enhance photothermal therapy in NSCLC. Nano Research. 16(1). 882–893. 10 indexed citations
9.
Li, Xia, et al.. (2022). Effect of Midwives’ Application of Intelligent Delivery Room Management System on Delivery Outcome. Computational and Mathematical Methods in Medicine. 2022. 1–5.
10.
Du, Hui, Ronghua Liu, Yongmei Guan, et al.. (2021). Proteomics and metabolomics analyses reveal the full spectrum of inflammatory and lipid metabolic abnormalities in dyslipidemia. Biomedical Chromatography. 35(10). e5183–e5183. 11 indexed citations
11.
He, Mingzhen, Junmao Li, Hui Du, et al.. (2021). Integrating the rapid constituent profiling strategy and multivariate statistical analysis for herb ingredients research, with Chinese official rhubarb and Tibetan rhubarb as an example. Arabian Journal of Chemistry. 14(8). 103269–103269. 18 indexed citations
12.
Wen, Quan, Ronghua Liu, Mingzhen He, et al.. (2020). PL-S2, a homogeneous polysaccharide from Radix Puerariae lobatae, attenuates hyperlipidemia via farnesoid X receptor (FXR) pathway-modulated bile acid metabolism. International Journal of Biological Macromolecules. 165(Pt B). 1694–1705. 46 indexed citations
13.
Gao, Shi, Bing Jia, Guo‐Kai Feng, et al.. (2020). First-in-human pilot study of an integrin α6-targeted radiotracer for SPECT imaging of breast cancer. Signal Transduction and Targeted Therapy. 5(1). 147–147. 10 indexed citations
15.
Xin, Hong, et al.. (2020). 17β-Estradiol improves osteoblastic cell function through the Sirt1/NF-κB/MMP-8 pathway. Climacteric. 23(4). 404–409. 12 indexed citations
16.
Chen, Ying & Hui Du. (2018). The promising PARP inhibitors in ovarian cancer therapy: From Olaparib to others. Biomedicine & Pharmacotherapy. 99. 552–560. 24 indexed citations
18.
Zhang, Mingle, Suolin Li, Xianghua Huang, et al.. (2016). Transumbilical single-incision laparoscopic vaginoplasty hybrid transperineal approach using a sigmoid colon segment: initial twenty-five cases. International Urology and Nephrology. 48(9). 1401–1406. 8 indexed citations
19.
Qian, Qi, Hui Du, Bernard F. King, et al.. (2008). Sirolimus Reduces Polycystic Liver Volume in ADPKD Patients. Journal of the American Society of Nephrology. 19(3). 631–638. 143 indexed citations
20.
Du, Hui, Shun‐le Chen, Chunde Bao, et al.. (2004). Prevalence and risk factors of knee osteoarthritis in Huang-Pu District, Shanghai, China. Rheumatology International. 25(8). 585–590. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026